Green Cross Corp
KRX:006280

Watchlist Manager
Green Cross Corp Logo
Green Cross Corp
KRX:006280
Watchlist
Price: 141 300 KRW 3.9%
Market Cap: 1.6T KRW
Have any thoughts about
Green Cross Corp?
Write Note

Green Cross Corp
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Green Cross Corp
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Green Cross Corp
KRX:006280
Net Income
-â‚©22.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Net Income
â‚©320.9B
CAGR 3-Years
-19%
CAGR 5-Years
7%
CAGR 10-Years
10%
SK Bioscience Co Ltd
KRX:302440
Net Income
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Net Income
â‚©119.4B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Net Income
â‚©90.8B
CAGR 3-Years
28%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Net Income
-â‚©5.1B
CAGR 3-Years
41%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

Green Cross Corp
Glance View

Market Cap
1.6T KRW
Industry
Biotechnology

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Yongin, Gyeonggi-Do. The firm mainly manufactures pharmaceutical products including blood products, general products, vaccines, over the counter (OTC) drugs, diagnostic reagents, placental injections, cell therapies, vaccine fertilized eggs and blood diagnostic products, among others. The firm also provides genome analysis services.

Intrinsic Value
216 064.68 KRW
Undervaluation 35%
Intrinsic Value
Price

See Also

What is Green Cross Corp's Net Income?
Net Income
-22.5B KRW

Based on the financial report for Sep 30, 2024, Green Cross Corp's Net Income amounts to -22.5B KRW.

What is Green Cross Corp's Net Income growth rate?
Net Income CAGR 1Y
-632%

Over the last year, the Net Income growth was -632%.

Back to Top